X4 Pharmaceuticals, Inc is a biopharmaceutical company based in Allston, MA, specializing in the development of novel therapies for individuals with chronic neutropenic disorders. Leveraging their expertise in diseases of the immune system and CXCR4 biology, they aim to bring innovative treatments to people suffering from these conditions.
Their lead product candidate, mavorixafor, is designed to enhance immune system function by enabling the mobilization of immune cells from the bone marrow into the bloodstream. With a focus on progress and a commitment to patients, X4 Pharmaceuticals is dedicated to advancing therapies that can make a difference in the lives of those affected by chronic neutropenic disorders.
Generated from the website